Cargando…
Angiotensin Receptor 1 Blockers Prolong Time to Recurrence after Radiofrequency Ablation in Hepatocellular Carcinoma patients: A Retrospective Study
Inhibition of angiotensin II synthesis seems to decrease hepatocellular carcinoma recurrence after radical therapies; however, data on the adjuvant role of angiotensin II receptor 1 blockers (sartans) are still lacking. Aim of the study was to evaluate whether sartans delay time to recurrence and pr...
Autores principales: | Facciorusso, Antonio, Abd El Aziz, Mohamed A., Cincione, Ivan, Cea, Ugo Vittorio, Germini, Alessandro, Granieri, Stefano, Cotsoglou, Christian, Sacco, Rodolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599746/ https://www.ncbi.nlm.nih.gov/pubmed/33050084 http://dx.doi.org/10.3390/biomedicines8100399 |
Ejemplares similares
-
Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials
por: Facciorusso, Antonio, et al.
Publicado: (2020) -
Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma
por: Abd El Aziz, Mohamed A., et al.
Publicado: (2020) -
Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
por: Facciorusso, Antonio, et al.
Publicado: (2020) -
Efficacy of Regorafenib in Hepatocellular Carcinoma Patients: A Systematic Review and Meta-Analysis
por: Facciorusso, Antonio, et al.
Publicado: (2019) -
Nucleos(t)ide analogues and Hepatitis B virus-related hepatocellular
carcinoma: A literature review
por: Abd El Aziz, Mohamed A, et al.
Publicado: (2020)